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Abstract 
Identification of gene products exclusively or abundantly expressed in hepatocellular carcinoma (HCC) and in normal iver may yield 
novel tumor markers. We have isolated 36 up- and down-regulated cDNAs from diethylnitrosamine-induced rat hepatocellular carcinoma 
and normal iver tissue by using the subtraction-enhanced display technique. Nucleotide sequence analysis revealed that the majority of 20 
subtraction-enriched cDNA fragments were well-characterized oncogenes and tumor-associated genes, like c-myc, a-prothymosin, p21, 
glutathione-S transferase (G-ST) and c~ l-acid glycoprotein (AGP). As demonstrated by Northern blot detection, all of them were 
preferentially expressed either in HCC or in normal liver (2- to 7-fold). As paradigm, G-ST and AGP were shown to be exclusively 
overexpressed in tumor nodules by in situ hybridization. In addition, 14 of the remaining 16 novel genes were analysed on Northern blot, 
10 of which were differentially expressed in HCC. 
Keywords: Hepatocellular-carcinoma; Tumor marker; Gel display; Subtractive-hybridization 
1. Introduction 
Hepatocellular carcinoma (HCC) is one of the most 
frequent malignancies in humans. Development of cancer 
results from a stepwise process involving different preneo- 
plastic lesions that reflect multiple genetic events like 
activation of proto-oncogene, inactivation of tumor-sup- 
pressor genes and over- or re-expression of growth factors 
[1]. Despite generally acknowledging that the majority of 
HCC cases are associated with interactive ffects of viral 
and chemical carcinogens, the latter have been widely used 
for analyzing multistep carcinogenesis and for generating 
animal models [2]. Being a potent carcinogen, diethylni- 
trosamine is considered to be a genotoxic tumor initiator. 
When administered continuously to rats, it produces in a 
dose-response relationship well-characterized tumors [3]. 
The molecular mechanisms underlying hepatocarcinogene- 
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sis and the major factors responsible for initiation and 
progression of HCC remain unclear. Inappropriately al- 
tered expression of oncogenes/tumor-suppressor genes is 
a common feature of neoplastic cells. Several genes have 
been identified which are abundantly or specifically pre- 
sent in tumorous tissue [4]. It is assumed that such genes 
might be involved in some steps in cell transformation. In
addition, the steady-state l vel of their transcripts may also 
provide information on the differentiation status of the 
hepatocytes, both during carcinogenesis and in fully devel- 
oped tumors [5]. 
We report here the identification of 36 up- and down- 
regulated gene products from rat HCC and the normal 
liver. These differentially expressed genes were identified 
by utilizing the subtraction enhanced-display technique [6], 
which involves depleting a cDNA population of species 
shared with the cDNA population with which it is com- 
pared by subtractive hybridization and subsequently identi- 
fying the remaining up- or down-regulated cDNA frag- 
ments on a display gel. The majority of gene products 
were tumor-associated factors and differentially expressed 
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in HCC. Moreover, the altered expression of l0 novel 
genes was found in HCC. 
2. Material and methods 
Liver specimens. Rat tumoral liver samples were ob- 
tained from Dr. S.-H. Yap, University Hospital, K.U. 
Leuven, Belgium. HCC had been chemically induced in 
Wistar rats by supplying diethylnitrosamine via the drink- 
ing water [7]. Tissue was confirmed as HCC by standard 
histopathologic techniques employing haematoxylin-eosin 
staining. Normal rat liver tissue was obtained from un- 
treated Wistar rats (250-300 g). 
Preparation of RNA and cDNA fragments. Total cellu- 
lar RNA was extracted from frozen liver tissue of both 
HCC and normal rat by a guanidium-thiocyanate-phenol- 
chloroform method [8]. Poly(A) + RNA was purified by 
means of oligo(dT) cellulose (Boehringer, Almere, The 
Netherlands) affinity chromatography. Oligo(dT)-NotI (In- 
vitrogen, San Diego, CA) was used to prime the first 
strand of cDNA synthesis from 5 /xg of poly(A) + RNA. 
Double-stranded cDNA was synthesized using a Promega 
Kit according to the manufacturer's instruction (Leiden, 
The Netherlands). To prepare cDNA fragments for the 
subtraction procedure, the method as described by Wang 
and Brown [9] was used with minor modifications. The 
cDNA fragment populations derived from HCC and nor- 
mal liver were ligated with the adaptors/primers 
(5 'CTCTTGCTTGAATTCGGACTA and 
5'ACTTAGCAAAGGCTTGCC), respectively. The liga- 
tion reactions were fractionated by electrophoresis through 
a 1.0% low-melting agarose gel in order to remove the 
unligated adaptors. The adaptor-linked AluI and 
AluI/RsaI cDNA fragments in the size range of 0.1-1 kb 
were combined. Finally, each cDNA fragment population 
was amplified by PCR utilizing Super Taq DNA poly- 
merase (Sphaero Q, Leiden, The Netherlands) and the 
respective specific primer (amplification conditions were: 
94°C for 1 min, 53°C for 1.5 rain, 72°C for 2 min, for 30 
cycles, followed by a final elongation step of 5 min at 
72°C). The amplified products were purified with 
QIAquick-spin PCR purification kit (QIAGEN, Hilden, 
Germany). 
Subtractive hybridization. Subtractive hybridization was 
performed to deplete common gene products in tumoral 
and normal liver tissue as previously documented [9]. To 
identify the differences in the spectrum of expressed genes 
in HCC and control RNA (cDNA), all experiments were 
done symmetrically, viz., the control cDNA fragments 
were used as driver and the HCC cDNA fragments as 
tracer, and vice versa. In brief, cDNA from driver cDNA 
population was amplified by PCR and photo-biotinylated 
(Vector Laboratories, Burlingame, CA) by exposure for 30 
min to a 300-W sun lamp (Philips, The Netherlands). In 
order to obtain the up- and down- regulated cDNAs, a 
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Fig. 1. Schematic representation of the flow diagram of subtractive 
hybridization, PCR amplification and purification. A 20-fold excess of 
biotinylated river cDNA fragments was combined with 2.5 /zg of tracer 
cDNA, denatured and hybridized for 20 h (long cycle of hybridization). 
Next the mixture was incubated with streptavidin, followed by extraction 
with phenol-chloroform. The remaining enriched cDNA was subjected to 
the above procedure for 2 h with 25 /xg of biotinylated river cDNA 
(short cycle of hybridization). This procedure was repeated once to obtain 
enriched up-regulated cDNAs from HCC. Enriched down-regulated 
cDNAs were isolated by using HCC-derived cDNAs as driver for the 
subtraction. 
20-fold excess of the biotinylated river cDNA was hy- 
bridized with 2.5 /zg of tracer cDNA at 65°C for 20 h 
(long cycle of hybridization). After incubation with 
streptavidine (GIBCO BRL, Breda, The Netherlands) for 
30 min at room temperature, the biotinylated cDNA-pro- 
tein complex was extracted with phenol/chloroform. For 
the short cycle of hybridization [9], the above procedure 
was repeated for only 2 h of hybridization. After the 
amplification by PCR (employing the specific primers) and 
purification, an additional round of long and short subtrac- 
tive hybridization was performed as described above (see 
flow diagram in Fig. 1). 
Display of subtraction-enriched cDNA population. To 
analyze and isolate the subtraction-enriched up- and 
down-regulated cDNA fragments from both HCC and 
normal control iver, we employed the display method [6]. 
The enriched cDNA fragments obtained after each round 
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of subtractive hybridization, as well as the initial cDNA 
fragments derived from HCC and normal liver, were am- 
plified using Taq DNA polymerase and the specific primers 
in the presence of 0.5 /zM [a-35S]dATP (1200 Ci/mmol, 
final volume 25 /zl). The experimental conditions were 
exactly the same as those used to generate the large 
quantities of cDNA needed for the actual subtractive hy- 
bridization, except hat the concentration of non-radioac- 
tive dATP was lowered from 200 /~M to 20 /~M to obtain 
a sufficiently high specific activity. Comparable amounts 
of amplified radiolabelled cDNAs were then subjected to 
electrophoresis on a 6% polyacrylamide DNA-sequencing 
gel. An X-ray film (Kodak) was exposed to the dried gel 
overnight. 
Sequence analysis. Distinctly enriched cDNA bands 
with 150-750 bases in length were individually excised 
from the display gel, boiled in 100 /xl of TE buffer (10 
mM Tris, t mM EDTA, pH 7.4) for 5 min. Subsequently, 
25 /zl of the aqueous cDNA extract was used to amplify 
the cDNA by PCR with the specific primer. The amplified 
cDNA fragment was directly cloned into the pCR ~" vector 
(Invitrogen). The recombined plasmid was transformed 
into INV~F' cells and plated out on ampicillin-IPTG 
(isopropylthio-/3-D-galactoside)-X-Gal (5-bromo-4-chloro- 
3-indolyl-/3-D-galactopyranoside)-agar plates. Six white 
colonies from each plate were randomly isolated and ana- 
lyzed for inserts on 1.2% agarose gel. Clones with inserts 
that varied in molecular size proceeded to the nucleotide 
sequencing step. In total, 36 selected cDNA fragments 
were sequenced by a standard sequencing method using 
the Sequenase USB kit (USBiochemical, Ohio, USA). 
Sequences of more than 150 base were compared with 
other previously reported nucleotide sequences in the Gen- 
Bank database, using the Blastn search. 
Northern blot. Total RNA (20 /~g) from HCC and 
normal liver tissue was separated on a 1% formaldehyde- 
agarose gel and transferred to Hybond-N nylon membrane 
(Amersham, UK). After fixation at 80°C for 2 h, the 
Northern blots were prehybridized for 2 h at 65°C in 
6XSSC (1 ×SSC=0.15  mol/1 NaCI/0.015 mol/1 
sodium citrate), 5 X Denhardt's olution, 0.5% SDS, 100 
/xg/ml of herring sperm DNA. Probes were isolated from 
low-melting el and labelled according to the hexamer-ran- 
dom primed method following the manufacturer's protocol 
(Promega). Blots were hybridized under the same condi- 
tions as stated for prehybridization. The filters were washed 
4 times for 15 min with 1 x SSC/0.1% SDS and once 
with 0.2 X SSC/0.1% SDS at 65°C. An X-ray film was 
exposed. The radiolabelled probes were then stripped from 
the membranes in a 0.1% SDS solution following the 
manufacturer's protocol (Amersham) and rehybridized with 
GAPDH (glyceraldehyde-3-phosphate dehydrogenase) 
cDNA, The membranes were scanned with a Phosphorim- 
ager radioanalytic scanning system (Molecular Dynamics, 
USA) in order to quantify the amount of radioactivity of 
individual bands. 
In situ hybridization. In situ hybridization was per- 
formed on serial sections of the HCC and normal rat liver 
tissue with a slight modification of the method described 
by Moorman et al. [10]. The probes used in this study were 
made from cDNA fragments of approx. 0.3-0.4 kb of 
G-ST and c~ 1-acid glycoprotein, labelled by the hexamer- 
random primed method using [a-35S]dATP (Amersham), 
to a spec. act. of 10 s cpm//zl. After pretreatment of the 
tissue sections as described [10], 7 X 10 4 cpm//xl of the 
labelled probe resuspended in hybridization mixture was 
applied to each section. Hybridization was performed 
overnight at 42°C. Sections were washed by gently shaking 
in two successive baths of 50% formamide in 1 X SSC for 
15 min at 42°C. Sections were then rinsed in 1 X SSC for 
2 X 10 min, 0.1 X SSC for 10 min at room temperature. 
After dehydration in graded ethanol containing 0.3 M 
ammonium acetate, the sections were dipped in Ilford 
Nuclear Research Emulsion G-5 (Ilford Photo, Leiden, The 
Netherlands). After 14-21 days of exposure, sections were 
developed in Amidol-developer (4-Hydroxy 1, 3-phenylen- 
ediammoniumdichloride) (Merck, Amsterdam, the Nether- 
lands), fixed in 30% NA2S203.H20 in distilled water and 
stained with 0.1% Nuclear fast red. 
3. Results 
Subtraction-enriched cDNA. In order to analyze directly 
the enrichment of cDNA fragments after each round of 
HCC NOR 
01  2 210  
, k -  
Fig. 2. Display of cDNA fragments on a 6% of polyacrylamide s quenc- 
ing gel after consecutive rounds of subtractive hybridization of HCC (left 
panel) and normal liver (right panel). Lane 0, 1, and 2 represent cDNA 
fragments before, and after I and 2 complete rounds of subtractive 
hybridization. To visualize the cDNA, it was amplified in the presence of 
[ot-35S]-labelled dATP and exposed to an X-ray film. The arrowheads 
indicate xamples of the enriched cDNA bands and the asterisk represents 
an unaffected cDNA fragment. 
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subtraction, the cDNA populations prepared from HCC 
and normal iver were compared on a sequence gel before 
and after each round of subtractive hybridization (Fig. 2). 
The majority of the cDNAs (lanes 0) in both initial popula- 
tions were poorly identifiable, indicating the presence of 
many cDNA fragments of different molecular size. In 
contrast, a number of distinct bands became visible after 
two rounds of subtraction, demonstrating the enrichment of 
fragments unique to either the HCC-derived (Fig. 2, left, 
HCC panel) or the normal liver-derived gene products 
(right, control panel). A few examples of enriched gene 
products are marked with arrowheads. Furthermore, a few 
bands (Fig. 2, lane 0) in the initial cDNA had disappeared, 
indicating that common cDNAs had been eliminated. In 
addition, some cDNA fragments, as indicated with an 
asterisk, remained unaffected by subtractive hybridization, 
which implied that additional rounds might be needed to 
remove them (Fig. 2). 
Isolation of up- and down-regulated gene products. 
Since the enrichment of specific cDNA fragments could be 
simply compared and analyzed on the display gel, such 
bands were precisely excised from the gel and representa- 
tive cDNAs were isolated and amplified. In the present 
report, 27 subtraction-enriched cDNA fragments from HCC 
Table 1 
Identification of the subtractively enriched cDNAs 
Fragment a Identity b Sequence c Northern blot d Molecular e 
no. similarity HCC Norm size 
1 c-myc 71% (H) + + + + 1.6 
2 o~-prothymosin 96% (R) + + + 0.8 
3 21-kDa protein 86% (M) + + + + 0.8 
4 glutathione-S transferase (Yb l )  100% (R) + + + + + 1.1 
5 ceruloplasmin (hepatic) 90% (H) + + + 2.8 
6 non-histone protein 89% (P) + + + + 1.1 
7 ot 1-acid glycoprotein 100% (R) + + + + + 0.7 
8 zinc-finger protein (ZFN20) 84% (H) + + + 1.4 
9 ferritin (heavy chain) 95% (M) + + + + + 0.8 
10 hnRNPc protein 90% (R) ND 
11 mus.B6D2F1 clone 100% (R) ND 
12 interferon alpha5 76% (M) ND 
13 ot-tocopherol transfer protein 100% (R) + + + + 2.1 
14 mtDNA 97% (R) ND 
15 Rbc 453 cDNA 92% (H) ND 
16 mtDNA 86% (R) ND 
17 novel + + + 1.2 
18 novel + + 1.3 
19 novel + + + 1.1 
20 novel + + + + + 1.0 
21 novel + + + 0.6 
22 novel + + 3.0 
23 novel + + + 1.4 
24 novel + + + + + 2.0 
25 novel + + + + 1.4 
26 novel + + + 1.2 
27 novel - - 
28 mtDNA 97% (R) ND 
29 mtDNA 96% (R) ND 
30 cytochrome oxidase 83% (M) ND 
31 electron trans, flavoprotein 85% (M) ND 
32 novel - - 
33 novel + + 1.1 
34 novel + + + 1.1 & 0.6 
35 novel + + 1.9 
36 novel + + + 1.2 
a Fragments 1-27 were isolated from HCC, while fragments 28-36 were from normal liver. 
b Identities of 36 cDNAs were obtained by comparison with sequences from GenBank. Note that sequences were compared to existing rat (R), mouse (M), 
pig (P) and human (H) sequence data. 
c Sequence was compared as described in text. Novel genes had no similarity. 
d Northern blot analysis were quantified with a Phosphoimager. A difference between HCC and normal liver, if smaller than 1.4-fold, was indicated as 
( + ), a 1.5- to 2.4-fold difference was indicated as ( + + ), a 2.5- to 3.4-fold difference as ( + + + ) and > 3.5-fold as ( + + + + ). ND: not done. ( - ): not 
detectable. 
e Size of mRNA detected on Northern blots. 
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Fig. 3. Northern blot analysis of 20 /xg total RNA hybridized with 5 
tumor-associated gene products of a-prothymosin, c-myc, 21-kDa pro- 
tein, G-ST and ferritin. T and N represent RNA derived from HCC and 
normal iver, respectively. The exposure was such that the fold-induction 
rather than the abundance in normal liver is stressed. The intensity of 
cDNA bands was quantitatively determined with the Phosphorimager and 
standardized by comparison to the GAPDH signal (Table 1). 
and 9 from normal liver tissue were analyzed (Table 1). 
Nucleotide sequence analysis revealed that the majority of 
20 cDNAs were well-characterized oncogenes and tumor- 
associated factors like c-myc, 21-kDa protein (p21), a-pro- 
thymosin, glutathione-S transferase yb-1 subunit (G-ST) 
and a 1-acid glycoprotein (AGP). The 16 novel genes 
showed no similarity with sequences reported in GenBank. 
Differential expression in HCC and normal liver. In 
order to detect the altered expression of these newly 
isolated gene products, we radiolabelled the subtraction- 
enriched cDNA fragments to assess the abundance of the 
corresponding mRNA in 20 /zg of total RNA from HCC 
and normal control liver on Northern blot. All known 
tumor-associated genes were detectable and the majority of 
them were found to be 2- to 7-fold more abundant in HCC 
(Table 1 and Fig. 3). More intriguingly, 14 out of 16 novel 
genes, so far, were detectable on Northern blot with sizes 
ranging from 0.6 to 3 kb (Table 1). Nine of these 14 were 
highly expressed in HCC and one in normal liver (Table 
1). The abundance of 6 clones was so low that they could 
only be visualized on blots of 5 /zg poly(A) + RNA and 
exposure for 2 weeks (not shown). In situ hybridization 
demonstrated that G-ST and AGP, which were shown to 
be up-regulated by Northern analysis, were exclusively 
overexpressed in the tumor nodules of HCC (Fig. 4). 
4. Discussion 
The extensive use of chemical carcinogens in rodents 
has provided an important and useful framework for study- 
ing the multistep process by which malignant tumors 
develop. There have been a number of reports, based on 
experimental nd theoretical studies, that pointed out that 
diethylnitrosamine acts both as an initiator and as a promo- 
tor in hepatocarcinogenesis [11,12]. Although a few au- 
thors have found some enhanced gene expression in dieth- 
ylnitrosamine-induced rat hepatoma [13] or in other car- 
cinogen-induced liver cancer [14], the full information on 
how oncogenes affect the phenotypic expression of HCC 
cells remains speculative from a molecular biologic point 
of view. In this study, we used the diethylnitrosamine-in- 
duced HCC model in Wistar rats to identify novel genes 
up- and down-regulated in HCC, by employing the sub- 
traction-enhanced display technique. 
The subtractive hybridization is a useful procedure to 
enrich those mRNAs (in the form of cDNA) that differ in 
Fig. 4, Expression of ot 1-acid glycoprotein and G-ST in normal rat liver (A and B) and in HCC (C and D). In serial sections of normal iver, a slight 
expression of a 1-acid glycoprotein (A) was observed in the periportal areas (pp), while preferential expression of G-ST (B) was detected in the pericentral 
areas (pc). In contrast, overexpression f both tx 1-acid glycoprotein and G-ST mRNA was found in the tumor nodules as indicated with the arrowheads. 
(magnification × 125). 
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concentration between two extracts. The method is based 
on the depletion of common gene products, thereby enrich- 
ing the specific species [9]. The technique has been devel- 
oped and used for many years. Nevertheless, the standard 
analysis of the outcome needs a screening hybridization 
assay and is, hence, laborious and time-consuming, since 
individual molecules have to be cloned and analyzed. 
Another technique to identify up-regulated genes in a 
population of mRNAs is the differential display developed 
by Liang and Pardee [15]. In this method, differential gene 
expression is visualized by comparison of the different 
intensities of cDNA fragments after electrophoretic separa- 
tion on a sequence gel. After conversion into cDNA using 
reverse transcriptase, all gene products can be amplified as 
distinct, primer-dependent groups of cDNAs. Although 
this procedure allows in principle the identification of all 
mRNAs, it cannot be used for isolating the rare gene 
products. Taking the best of both, we more readily identi- 
fied the enrichment of differentially expressed gene prod- 
ucts. The subtraction-enriched cDNA fragments derived 
from HCC and normal liver were displayed on the poly- 
acrylamide gel and could be analyzed without any further 
screening procedure. Furthermore, we could directly use 
the newly isolated cDNAs to make radiolabelled probes 
for Northern analysis (Fig. 3) and for in situ hybridization 
detection of the differentially expressed mRNAs (Fig. 4). 
Due to the power of the PCR, we were able to identify 
gene transcripts o under-represented hat some could only 
be visualized on Northern blot after 5 /xg poly(A) + RNA 
was loaded and the film was exposed for two weeks (not 
shown). The observation confirmed one of the advantages 
of the present approach in isolating the rare gene products 
over the conventional subtraction method without PCR 
amplification of the subtracted product. 
Among the up-regulated cDNAs derived from HCC 
which are entirely or highly similar to previously reported 
genes, the majority are well-characterized tumor-associated 
proteins. The reason that cDNAs like c-myc and 21-kDa 
protein isolated from rat liver showed different sequence 
homology (71-100%) with previously reported genes was 
mainly due to the different species we compared with, e.g., 
c-myc from human, 21-kDa protein from mouse. Among 
the well known tumor-associated factors the following can 
be recognised: (i) Tumor markers: liver G-ST has been 
used widely in numerous tudies, especially in hepatocar- 
cinogenesis, including HCC induced by diethylnitrosamine 
[16]; AGP has been applied as a tumor marker in clinical 
detection [17]. In this study, the quantitative analysis on 
Northern blot demonstrated both products to be overex- 
pressed in HCC. Moreover, in situ hybridization of G-ST 
and AGP confirmed that these two genes are particularly 
overexpressed in the tumor nodules. These findings with 
our approach to identify up- and down-regulated genes are, 
therefore, consistent with all previous tudies showing that 
G-ST and AGP are up-regulated in chemical hepatocar- 
cinogenesis. (ii) Oncogenes: c-myc was reported to be 
increasingly expressed going from normal to adjacent, 
uninvolved liver, to cirrhotic liver and finally to well-dif- 
ferentiated HCC [18]. In addition, activation of c-myc led 
to a rapid increase in transcription of c~-prothymosin, 
which may play a role in the proliferation of mammalian 
cells [19]. The up-regulation of both mRNAs that we found 
in this study implies that the increased transcription of 
c~-prothymosin may result from c-myc activation. (iii) 
Transcription factors: p21 was shown to be a downstream 
mediator in the cell cycle that is regulated by p53 tumor 
suppressor gene [20]; Non-histone chromosomal protein 
was found to be overexpressed in high-grade prostatic 
cancer [21]. Our study indicates that it might be involved 
in the hepatic carcinogenesis a well. The biologic behav- 
ior of above-mentioned transcription factors in this HCC 
model needs to be further elucidated. More excitingly, 
however, more than 70% of novel genes were shown to be 
differentially expressed on Northern blot in HCC. Further 
characterization f the novel genes is being carried out. 
In summary, we have identified 36 up- and down-regu- 
lated cDNAs from HCC and normal liver, using the sub- 
traction-enhanced display technique. The majority of them 
were tumor-associated factors and were confirmed to be 
overexpressed in HCC. The novel approach was found to 
be a simple and reliable method for the isolation of 
differentially expressed genes. Moreover, the identification 
of a number of novel genes differentially expressed in 
HCC and normal iver is an important first step to make an 
inventory of up- and down-regulated gene products in 
HCC. The availability of such an inventory should allow 
us to identify novel oncogenes and tumor-suppressor genes 
which might be applied as tumor markers for human HCC. 
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